vs

Side-by-side financial comparison of Eventbrite, Inc. (EB) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $73.5M, roughly 1.7× Eventbrite, Inc.). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -3.9%). Zai Lab Ltd produced more free cash flow last quarter ($-26.7M vs $-60.9M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs -7.7%).

Eventbrite is an American live events marketplace and website. The service allows users to browse, create, and promote local events. It is free to publish unlimited events of any size on Eventbrite.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

EB vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.7× larger
ZLAB
$127.1M
$73.5M
EB
Growing faster (revenue YoY)
ZLAB
ZLAB
+21.0% gap
ZLAB
17.1%
-3.9%
EB
More free cash flow
ZLAB
ZLAB
$34.2M more FCF
ZLAB
$-26.7M
$-60.9M
EB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
-7.7%
EB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EB
EB
ZLAB
ZLAB
Revenue
$73.5M
$127.1M
Net Profit
$-8.2M
Gross Margin
68.1%
51.0%
Operating Margin
-12.4%
-54.6%
Net Margin
-11.1%
Revenue YoY
-3.9%
17.1%
Net Profit YoY
2.5%
EPS (diluted)
$-0.08
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EB
EB
ZLAB
ZLAB
Q4 25
$73.5M
$127.1M
Q3 25
$71.7M
$115.4M
Q2 25
$72.8M
$109.1M
Q1 25
$73.8M
$105.7M
Q4 24
$76.5M
$108.5M
Q3 24
$77.8M
$101.8M
Q2 24
$84.6M
$100.1M
Q1 24
$86.3M
$87.1M
Net Profit
EB
EB
ZLAB
ZLAB
Q4 25
$-8.2M
Q3 25
$6.4M
$-36.0M
Q2 25
$-2.1M
$-40.7M
Q1 25
$-6.6M
$-48.4M
Q4 24
$-8.4M
Q3 24
$-3.8M
$-41.7M
Q2 24
$1.1M
$-80.3M
Q1 24
$-4.5M
$-53.5M
Gross Margin
EB
EB
ZLAB
ZLAB
Q4 25
68.1%
51.0%
Q3 25
67.9%
59.5%
Q2 25
67.5%
60.6%
Q1 25
66.9%
63.6%
Q4 24
68.2%
61.5%
Q3 24
68.5%
64.1%
Q2 24
70.9%
64.9%
Q1 24
71.0%
61.4%
Operating Margin
EB
EB
ZLAB
ZLAB
Q4 25
-12.4%
-54.6%
Q3 25
-1.3%
-42.3%
Q2 25
-8.7%
-50.3%
Q1 25
-13.2%
-53.3%
Q4 24
-10.2%
-62.6%
Q3 24
-11.5%
-66.6%
Q2 24
-7.6%
-76.0%
Q1 24
-8.8%
-80.7%
Net Margin
EB
EB
ZLAB
ZLAB
Q4 25
-11.1%
Q3 25
8.9%
-31.2%
Q2 25
-2.9%
-37.3%
Q1 25
-9.0%
-45.8%
Q4 24
-11.0%
Q3 24
-4.8%
-40.9%
Q2 24
1.3%
-80.2%
Q1 24
-5.2%
-61.4%
EPS (diluted)
EB
EB
ZLAB
ZLAB
Q4 25
$-0.08
$-0.05
Q3 25
$0.06
$-0.03
Q2 25
$-0.02
$-0.04
Q1 25
$-0.07
$-0.04
Q4 24
$-0.09
$-0.09
Q3 24
$-0.04
$-0.04
Q2 24
$0.01
$-0.08
Q1 24
$-0.05
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EB
EB
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$299.9M
$689.6M
Total DebtLower is stronger
$144.4M
Stockholders' EquityBook value
$179.1M
$715.5M
Total Assets
$647.2M
$1.2B
Debt / EquityLower = less leverage
0.81×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EB
EB
ZLAB
ZLAB
Q4 25
$299.9M
$689.6M
Q3 25
$717.2M
Q2 25
$732.2M
Q1 25
$757.3M
Q4 24
$441.5M
$779.7M
Q3 24
$24.7M
$616.1M
Q2 24
$56.7M
$630.0M
Q1 24
$113.7M
$650.8M
Total Debt
EB
EB
ZLAB
ZLAB
Q4 25
$144.4M
Q3 25
$174.9M
Q2 25
$241.3M
Q1 25
$241.0M
Q4 24
$240.7M
Q3 24
$240.4M
Q2 24
$358.7M
Q1 24
$358.2M
Stockholders' Equity
EB
EB
ZLAB
ZLAB
Q4 25
$179.1M
$715.5M
Q3 25
$189.1M
$759.9M
Q2 25
$177.2M
$791.7M
Q1 25
$173.3M
$810.8M
Q4 24
$170.2M
$840.9M
Q3 24
$179.8M
$667.7M
Q2 24
$176.2M
$704.2M
Q1 24
$184.1M
$762.2M
Total Assets
EB
EB
ZLAB
ZLAB
Q4 25
$647.2M
$1.2B
Q3 25
$744.6M
$1.2B
Q2 25
$784.1M
$1.2B
Q1 25
$812.3M
$1.2B
Q4 24
$752.3M
$1.2B
Q3 24
$817.4M
$985.3M
Q2 24
$894.5M
$987.4M
Q1 24
$952.2M
$988.4M
Debt / Equity
EB
EB
ZLAB
ZLAB
Q4 25
0.81×
Q3 25
0.92×
Q2 25
1.36×
Q1 25
1.39×
Q4 24
1.41×
Q3 24
1.34×
Q2 24
2.04×
Q1 24
1.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EB
EB
ZLAB
ZLAB
Operating Cash FlowLast quarter
$-60.8M
$-26.0M
Free Cash FlowOCF − Capex
$-60.9M
$-26.7M
FCF MarginFCF / Revenue
-82.8%
-21.0%
Capex IntensityCapex / Revenue
0.0%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.6M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EB
EB
ZLAB
ZLAB
Q4 25
$-60.8M
$-26.0M
Q3 25
$36.7M
$-32.0M
Q2 25
$-17.5M
$-31.0M
Q1 25
$59.4M
$-61.7M
Q4 24
$-45.3M
$-55.8M
Q3 24
$44.6M
$-26.8M
Q2 24
$-32.3M
$-42.2M
Q1 24
$68.6M
$-90.1M
Free Cash Flow
EB
EB
ZLAB
ZLAB
Q4 25
$-60.9M
$-26.7M
Q3 25
$36.6M
$-35.0M
Q2 25
$-17.5M
$-33.9M
Q1 25
$59.4M
$-63.2M
Q4 24
$-45.3M
$-58.4M
Q3 24
$44.4M
$-28.2M
Q2 24
$-32.4M
$-42.9M
Q1 24
$68.2M
$-91.1M
FCF Margin
EB
EB
ZLAB
ZLAB
Q4 25
-82.8%
-21.0%
Q3 25
51.1%
-30.4%
Q2 25
-24.1%
-31.1%
Q1 25
80.4%
-59.9%
Q4 24
-59.2%
-53.8%
Q3 24
57.1%
-27.7%
Q2 24
-38.3%
-42.9%
Q1 24
79.1%
-104.5%
Capex Intensity
EB
EB
ZLAB
ZLAB
Q4 25
0.0%
0.5%
Q3 25
0.0%
2.6%
Q2 25
0.0%
2.6%
Q1 25
0.1%
1.5%
Q4 24
0.0%
2.4%
Q3 24
0.2%
1.3%
Q2 24
0.1%
0.7%
Q1 24
0.4%
1.1%
Cash Conversion
EB
EB
ZLAB
ZLAB
Q4 25
Q3 25
5.76×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-30.37×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EB
EB

US$52.0M71%
Other$21.6M29%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons